430 related articles for article (PubMed ID: 11700151)
1. Olanzapine: a review of its use in the treatment of bipolar I disorder.
Bhana N; Perry CM
CNS Drugs; 2001; 15(11):871-904. PubMed ID: 11700151
[TBL] [Abstract][Full Text] [Related]
2. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
3. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine: an updated review of its use in the management of schizophrenia.
Bhana N; Foster RH; Olney R; Plosker GL
Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine alone or in combination for acute mania.
Rendell JM; Gijsman HJ; Keck P; Goodwin GM; Geddes JR
Cochrane Database Syst Rev; 2003; 2003(3):CD004040. PubMed ID: 12918000
[TBL] [Abstract][Full Text] [Related]
8. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
Tohen M; Ketter TA; Zarate CA; Suppes T; Frye M; Altshuler L; Zajecka J; Schuh LM; Risser RC; Brown E; Baker RW
Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
11. The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania.
Baker RW; Goldberg JF; Tohen M; Milton DR; Stauffer VL; Schuh LM
Bipolar Disord; 2002 Feb; 4(1):43-9. PubMed ID: 12047494
[TBL] [Abstract][Full Text] [Related]
12. The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
Hirschfeld RM; Baker JD; Wozniak P; Tracy K; Sommerville KW
J Clin Psychiatry; 2003 Jul; 64(7):841-6. PubMed ID: 12934987
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine: a review of its use in bipolar disorder.
Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
Drugs; 2003; 63(19):2029-50. PubMed ID: 12962521
[TBL] [Abstract][Full Text] [Related]
14. Spotlight on lamotrigine in bipolar disorder.
Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
[TBL] [Abstract][Full Text] [Related]
15. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
Chwieduk CM; Scott LJ
CNS Drugs; 2011 Mar; 25(3):251-67. PubMed ID: 21323396
[TBL] [Abstract][Full Text] [Related]
16. Acute dysphoric mania: treatment response to olanzapine versus placebo.
Baker RW; Tohen M; Fawcett J; Risser RC; Schuh LM; Brown E; Stauffer VL; Shao L; Tollefson GD
J Clin Psychopharmacol; 2003 Apr; 23(2):132-7. PubMed ID: 12640214
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on olanzapine in bipolar I disorder.
McCormack PL; Wiseman LR
CNS Drugs; 2005; 19(6):553-5. PubMed ID: 15963003
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine versus divalproex in the treatment of acute mania.
Tohen M; Baker RW; Altshuler LL; Zarate CA; Suppes T; Ketter TA; Milton DR; Risser R; Gilmore JA; Breier A; Tollefson GA
Am J Psychiatry; 2002 Jun; 159(6):1011-7. PubMed ID: 12042191
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.
Tohen M; Jacobs TG; Grundy SL; McElroy SL; Banov MC; Janicak PG; Sanger T; Risser R; Zhang F; Toma V; Francis J; Tollefson GD; Breier A
Arch Gen Psychiatry; 2000 Sep; 57(9):841-9. PubMed ID: 10986547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
